Thrombopoietin and thrombospondin in renal allograft recipients

Blood Coagulation and Fibrinolysis

Volumn 10, Issue 5, 1999, Pages 233-237

  Altun, B ^a   Usalan, C ^a   Haznedaroglu, I C ^a   Arici, M ^a   Ulusoy, S ^a   Erdem, Y ^a   Yasavul, U ^a   Turgan, C ^a   Caglar S ^a   Kirazli, S ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Platelets; Renal transplantation; Thrombopoietin; Thrombospondin

Indexed keywords

CREATININE; THROMBOPOIETIN; THROMBOSPONDIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERCOAGULABILITY; KIDNEY ALLOGRAFT; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTOPOIESIS;

EID: 0032815756     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199907000-00003     Document Type: Article

References (31)

1. 1. De Sauvage FJ, Hass PE, Spencer SD, Malloy BE, Gurney AL, Spencer SA, et al. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 1994; 369: 533-538.
2. 2. Lok S, Kaushansky K, Holly RD, Kuijper JI, Lofton Day CE, Ort PJ, et al. Cloning and expression of murine tbrombopoietin cDNA and stimulation of platelet production in vivo. Nature 1994; 369: 565-568.
3. 3. Debili N, Wendling F, Cosman D, Titeux M, Florindo C, Dusanter Fourt I, et al. The Mpl receptor is expressed in megakaryocyric lincage from the late progenitors to platelets. Blood 1995; 85: 391-401.
4. 4. Sungaran R, Markovic B, Chong BH. Localization and regulation of thrombopoietin mRNA expression in human kidney, liver, bone marrow and spleen using in situ hybridization. Blood 1996; 87: 1833-1844.
5. 5. Ezumi Y, Takayama H, Okuma M. Thrombopoietin, c-mpl-ligand, induces tyrosine phosphorylation of Tyk 2, JAK 2 and STAT 3 and enhances agonist induced aggregation in platelets in vitro. FEBS Lett 1995; 374: 48-52.
6. 6. Toombs CF, Young CH, Glaspy JA, Varnum BC. Recombinant human megakaryocyte growth and development factor (MGDF) moderately enhances ex vivo platelet aggregation by a receptor dependent mechanism. Thromb Res 1995; 80: 23-33.
7. 7. Baenziger N, Brodic G, Majerus P. Isolation and properties of thrombin sensitive protein of human platelets. J Biol Chem 1972; 247: 2723-2731.
8. 8. Wolff R, Plow EF, Ginsberg MH. Interaction of thrombospondin with resting and stimulated platelets. J Biol Chem 1986; 261: 6840-6846.
9. 9. Lawler J. The structural and functional properties of thrombospondin. Blood 1986; 67: 1197-1209.
10. 10. Leung LL. Role of thrombospondin in platelet aggregation. J Clin Invest 1984; 74: 1764-1772.
11. 11. Tuzynski GP, Rothman VL, Murphy A, Siegler K, Knudsen KA. Thrombospondin promotes platelet aggregation. Blood 1988; 72: 109-115.
12. 12. Vanrenterghem Y, Roels L, Lerut T. Thromboembolic complications and haemostatic changes in cyclosporine-treated cadaveric kidney allograft recipients. Lancet 1985; i: 999-1002.
13. 13. Levi M, Wilmink J, Büller HR, Surachno J, Cate JV. Impaired fibrinolysis in cyclosporine treated renal transplant recipients. Transplantation 1992; 54: 978-983.
14. 14. Cohen H, Neild GH, Patel R, Mackie IJ, Machin SJ. Evidence for chronic platelet hyperaggregability and in vivo activation in cylosporine treated renal allograft recipients. Thromb Res 1988; 49: 91-96.
15. 15. Nichol JL. Thrombopoietin levels after chemotherapy and naturally occurring human diseases. Curr Opin Hematol 1998; 5: 203-208.
16. 16. Cohen Solal K, Villeval JL, Titeux M, Lok S, Vainchenker W, Wendling F. Constitutive expression of Mpl ligand transcript during thrombocytopenia and thrombocytosis. Blood 1996; 88: 2578-2584.
17. 17. Stoffer R, Wiestner A, Skoda RC. Thrombopoietin in thrombocytopenic mice: evidence against regulation at mRNA level and for a direct regulatory role of platelets. Blood 1996; 87: 567-573.
18. 18. Shimodaira N, Ishida F, Ichikawa N, Tahara T, Kato T, Kadaira T, et al. Serum thrombopoeitin levels in patients with liver cirrhosis. Thromb Haemost 1996; 76: 545-548.
19. 19. Martin TG, Somberg KA, Meng YG, Cohen RL, Heid CA, De Sauvage FJ, et al, Thrombopoietin levels in patients with cirrhosis before and after orthotoptic liver transplantation. Ann Intern Med 1997; 127: 285-288.
20. 20. Vannuchi AM, Grossi A, Bosi A, Rafanelli D, Guidi S, Saccardi R, et al. Impaired crythropoietin production in mice treated with cyclosporine A. Blood 1991; 78: 1615-1618.
21. 21. Wollf M, Jelkmannn W. Effects of chemotherapeutic and immunosuppressive drugs on the production of erythropoietin in human hepatoma cultures. Ann Hematol 1993; 66: 27-31.
22. 22. Kuter DJ, Rosernberg RD. The reciprocal relationship of thrombopoietin to changes in platelet mass during busulfan induced thrombocytopenia in rabbit. Blood 1995; 85: 2720-2730.
23. 23. Fielder PJ, Gurney AL, Stefanich E. Regulation of thrompoietin levels by c-mpl mediated binding to platelets. Blood 1996; 87: 2154-2161.
24. 24. Ichikawa N, Ishida E, Shimodaira S, Tahara T, Kato T, Kitano K. Regulation of serum thrombopoietin levels by platelets and megakaryocytes in patients with aplastic anemia and idiopathic thrombocytopenic purpura. Thromb Haemost 1996; 76: 156-160.
25. 25. Cerutti A, Custodi P, Duranti M, Noris P, Balduni CL. Thrombopoietin levels in patients with primary and reactive thrombocytosis. Br J Haematol 1997; 99: 281-284.
26. 26. Baker LRI, Tucker B, Kovac IB. Enhanced in vitro hemostasis and reduced thrombolysis in cyclosporine-treated renal transplant recipients. Transplantation 1990; 49: 905-909.
27. 27. Cohen H, Neild GH, Patel R, Mackie IJ, Machin J. Evidence for chronic platelet hyperaggregability and in vivo activation in cylosporine treated renal allograft recipients. Thromb Res 1988; 49: 91-95.
28. 28. Grace AA, Barradas MA, Mikhailidis DP. Cyclosponne A enhances platelet aggregation. Kidney Int 1987; 32: 889-895.
29. 29. Malyszko J, Malyszko JS, Pawlak K, Mysliwiec M. The coagulo-lytic system and endothelial function in cyclosporine treated kidney allograft recipients. Transplantation 1996; 62: 828-830.
30. 30. Leung LLK, Nachman RL. Complex formation of platelet with thrombospondin with fibrinogen. J Clin Invest 1982; 70:542-548.
31. 31. Agbanyo F, Sixma J, Groot P, Languino LR, Plow EF. Thrombospondin-platelet interactions. J Clin Invest 1993; 92: 288-296.